Skip to main content
Account

Peer review reports

From: A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours

Original Submission
29 Jul 2020 Submitted Original manuscript
17 Sep 2020 Reviewed Reviewer Report - Joseph Abi Jaoude
22 Sep 2020 Reviewed Reviewer Report
20 Oct 2020 Author responded Author comments - Yvonne LE Ang
Resubmission - Version 2
20 Oct 2020 Submitted Manuscript version 2
21 Oct 2020 Reviewed Reviewer Report - Joseph Abi Jaoude
26 Oct 2020 Reviewed Reviewer Report
2 Nov 2020 Author responded Author comments - Yvonne LE Ang
Resubmission - Version 3
2 Nov 2020 Submitted Manuscript version 3
Publishing
4 Nov 2020 Editorially accepted
17 Nov 2020 Article published 10.1186/s12885-020-07616-4

Learn about peer review

Back to article page

Navigation